"SER-109, an Investigational Microbiome Drug for Recurrent Clostridioides difficile Infection: Lessons Learned from a Phase 2 Trial."
Poster Provided by:
Seres Therapeutics
Poster Presentation by:
Christopher Ford, Ph.D.
Senior Director, R&D
Computational Microbiome Sciences
"A Rationally-Designed Consortium (VE303) For Prevention of Clostridioides difficile Recurrence."
Poster Provided by:
Vedanta BioSciences
Poster Presentation by:
Jeffrey Silber, MD, Chief Medical Officer
Bernat Olle, Ph.D., Chief Executive Officer
"Prevention Of Recurrent Clostridioides difficile Infection at Two Years After Treatment with Investigational Microbiota-Based Drug RBX2660: Efficacy, Durability, Microbiome Changes, and Participant Demographics of a Phase 2
Open-Label Clinical Trial."
Poster Provided by
Rebiotix (a Ferring Company)
Poster Presentation by:
Courtney Jones
Associate Director, Marketing and Communications
“TECHLAB QUIK CHEK EIA Technology.”
Poster Provided by
TechLab
"A Phase 2 Clinical Trial Evaluating a Novel Antibiotic Against a CDI."
Poster Provided by
Deinove
Poster Presentation by:
Yannick Pletan, MD, MSc, HEC
Chief Medical Officer
To Learn More About Poster and Corporate Presentations, Take a Moment and View/Download the Following Information
LATE BREAKER:
Ibezapolstat Clinical Update
Presented by:
Kevin W. Garey, PharmD, MS
Professor and Chair
University of Houston College of Pharmacy
"DNA Polymerase IIIC Inhibitor Ibezapolstat, First Of a New Class of Antibiotics With a Novel Mechanism of Action; Clinical Trial Update."
Poster Presentation by:
Kevin W. Garey, PharmD, MS
Professor and Chair
University of Houston College of Pharmacy
“Engaging Middle School Children In Infection Prevention Through the
C Diff Foundation’s
Junior Infection Fighters Program."
Poster Presentation by:
Maureen Spencer, M.Ed, BSN, RN, CIC, FAPIC
"Widespread Mattress Failure in a US Hospital."
Poster Presentation by
Edmond A. Hooker, MD, DrPH
This presentation shares the simulation of the Sporalizer and additional information regarding the project.
Goden Pandas Virtual Video Presentation.
This video delivers a brief introduction to:
* C. diff.,
* A simulation of the Sporalizer,
* And footage from their at-home experiments.
"Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for
Clostridioides diffiicle Infection."
Poster Provided by
Progenabiome
Poster Presentation by
Sabine Hazan Steinberg, MD
Gastroenterology/Hepatology/Internal Medicine
"DAV132 Protects the Intestinal Microbiota of Patients Treated with Fluoroquinolones.
A European Phase II Randomized Controlled Trial (SHIELD)."
Poster Presentation provided by
DaVolterra
Poster Presentation by:
Jean DeGunzburg, Ph.D.
Chief Scientific Officer
"An Investigational Orally Administered Microbiome Drug, CP101, for the Prevention of Recurrent C. difficile Infection: A Randomized, Placebo-Controlled, Multi-Center Trial (PRISM3) ."
Poster Provided by:
Finch Therapeutics
Poster Presentation by:
Jessica R. Allegretti, MD, MPH (Brigham & Women's Hospital and Harvard Medical School, Boston)
"Evaluation Of a Novel Antimicrobial Textile Intervention For Inclusion In An Infection Control Program Through a Retrospective Analyses Of
Hospital-Acquired Infection (HAI) Rates."
Poster Provided by
Applied Silver
Poster Presentation by
Dr. Priya Balachandran, Ph.D.
Chief Operations Officer
UV-C is a powerful tool to kill pathogens, but how do you know if you’ve delivered a lethal dose?
Join Wendy Brady as she explains how UVC Dosimeters
by Intellego Technologies
providing visible evidence of successful ultraviolet disinfection, so you can truly SEE you’ve hit your mark to kill C. diff. spores, MRSA, and even
SARS-CoV-2.
Intellego Technologies